Search clinical trials for: Target ALS

Total 7674 results

Gipfel Life Sciences GmbH

Not yet recruiting

This Study Evaluates the Safety, Target Engagement, and Preliminary Efficacy of Galunisertib (TGF-βR1/ALK5 Inhibitor)Combined With Nerandomilast (PDE4 Inhibitor) in GREM2-positive ALS, a Biomarker-defined Subgroup Hypothesized to Reflect Heightened TGF-β/SMAD-driven Astrocytic and Fibrotic Signaling

ALS (Amyotrophic Lateral Sclerosis)
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...
IRCCS San Raffaele; Azienda Ospedaliero Universitaria di Cagliari; Università...

Recruiting

Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy (TUNEABLE)

Amyotrophic Lateral Sclerosis (ALS) | Peripheral Neuropathies

Italy
Target ALS Foundation, Inc.

Recruiting

Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home Measures (TALSLB)

Movement Disorders | Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Degenerative Disorder

United States, Colombia, Puerto Rico
The University of Queensland
King's College London; UMC Utrecht; Julius Clinical; FightMND

Completed

Targeting Metabolic Flexibility in Amyotrophic Lateral Sclerosis (ALS) (MetFlex)

Motor Neuron Disease | Amyotrophic Lateral Sclerosis

Netherlands, United Kingdom, Australia
Data Collection Analysis Business Management
PAS Research Services

Unknown

Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies

Hereditary Cancer

United States

Search clinical trials for: Target ALS

This is a preview